1.
Pulm Circ
; 14(2): e12326, 2024 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38623409
RESUMEN
Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pulmonary hypertension centers and combination therapy with PAH agents from different classes were less likely to result in discontinuation.